As per MRFR analysis, the Pharmaceutical Gelatin Market Size was estimated at 3.21 (USD Billion) in 2023.The Pharmaceutical Gelatin Market Industry is expected to grow from 3.35(USD Billion) in 2024 to 5.4 (USD Billion) by 2035. The Pharmaceutical Gelatin Market CAGR (growth rate) is expected to be around 4.44% during the forecast period (2025 - 2035).
Key Pharmaceutical Gelatin Market Trends Highlighted
The Pharmaceutical Gelatin Market is seeing significant changes that are being driven by a variety of causes. The pharmaceutical industry's growing demand for gelatin is driven mostly by its widespread usage in the manufacture of capsules and drug delivery systems. This trend is due in part to an increasing preference for gelatin-based formulations over synthetic alternatives, which are thought to be more biocompatible and safer to consume.
Furthermore, the aging population increases the need for drugs, increasing demand for pharmaceutical gelatin, which is utilized in prescriptions and nutritional supplements. Market opportunities abound, particularly with the rise of gelatin uses in the vaccine business.
With continued improvements in vaccine manufacture and biotechnology, gelatin is emerging as a vital component for vaccine stabilization and efficacy. Another interesting topic for further exploration is gelatin's capacity to increase medication bioavailability, particularly in novel drug formulations aimed at improving therapeutic results.
Recent trends show an increasing emphasis on sustainability and sourcing techniques in the pharmaceutical gelatin production process. Manufacturers are increasingly searching for sustainable raw material procurement, including vegan options and verified sources.
This shift aligns with worldwide health legislation and customer demand for ethically produced products. Furthermore, advances in technology and manufacturing techniques are simplifying gelatin production, making it more efficient and cost-effective, hence helping the worldwide pharmaceutical gelatin market's overall development trajectory.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharmaceutical Gelatin Market Drivers
Increasing Demand for Capsules and Soft Gelatin Forms
The Pharmaceutical Gelatin Market Industry is witnessing a robust demand for capsules and soft gelatin formulations. With the rise in the consumption of dietary supplements and pharmaceuticals, the global demand for gelatin-based capsules is set to surge. Recent data from the Food and Drug Administration indicates that nearly 40% of all prescription medications are provided in capsule form, demonstrating a critical market segment.
Organizations like the Pharmaceutical Manufacturers Association are advocating for gelatin usage in drug formulations, pointing out that nearly 60% of physicians prefer capsules for both their ease of administration and patient compliance.
This trend is expected to significantly drive the growth of the Pharmaceutical Gelatin Market Industry, reflecting an adaptation of drug delivery systems that meet patient needs while enhancing therapeutic effectiveness.
Rising Preference for Vegan and Vegetarian Alternatives
The Pharmaceutical Gelatin Market Industry is experiencing a shift towards vegetarian and vegan alternatives to traditional animal-based gelatin. With an increasing number of health-conscious consumers and a notable rise in dietary restrictions, there is a growing preference for plant-based gelling agents. For instance, the Vegetarian Resource Group reports that almost 20% of Americans are now identifying as vegans or vegetarians, which greatly influences pharmaceutical companies to explore options like agar or pectin.
Major pharmaceutical firms are adjusting their product lines to cater to this demographic, thus catalyzing growth and expansion within the Pharmaceutical Gelatin Market Industry.
Technological Advancements in Gelatin Production
Advancements in gelatin production technology are playing a pivotal role in the growth of the Pharmaceutical Gelatin Market Industry. Innovative extraction techniques and better purification processes have significantly improved the quality of gelatin. According to reports from the Food Chemical Codex, new methods have enhanced the yield of gelatin while reducing potential contaminants, resulting in higher quality products. Leading organizations such as Gelita AG are at the forefront of implementing these innovations, demonstrating a commitment to quality and efficiency.
The emphasis on quality control and superior manufacturing techniques is expected to drive market growth as pharmaceutical companies increasingly seek reliable suppliers for their gelatin needs.
Pharmaceutical Gelatin Market Segment Insights
Pharmaceutical Gelatin Market Application Insights
The Pharmaceutical Gelatin Market is primarily segmented into Applications, which represent a significant area within the industry. In 2024, the valuation of this market is expected to reach 3.35 USD Billion, showcasing a healthy growth trajectory.
This segment includes various applications such as Capsules, Tablets, Suppositories, and Vaccines, each playing a critical role in the pharmaceutical sector. Capsules hold a prominent position, valued at 1.1 USD Billion in 2024 and projected to rise to 1.8 USD Billion by 2035, indicating a majority holding in the overall application sector.
Their popularity stems from their effectiveness in delivering doses in a palatable form, along with their ability to mask unpleasant tastes. Tablets follow closely with an initial valuation at 1.2 USD Billion in 2024, expected to reach 2.0 USD Billion in 2035. This growth reflects the high demand for solid dosage forms that offer versatility and ease of application for patients, making them a staple in daily pharmaceutical consumption.
Suppositories, valued at 0.7 USD Billion in 2024 and growing to 1.1 USD Billion by 2035, serve as an essential alternative for patients who may have difficulties with oral medication, particularly in pediatric and geriatric care, thus underlining their significance in the overall market landscape.
Lastly, Vaccines, although relatively smaller in comparison, with a valuation of 0.35 USD Billion in 2024, rising to 0.5 USD Billion by 2035, are increasingly important as a preventive measure in healthcare, especially in light of recent global health challenges. This application segment of the Pharmaceutical Gelatin Market reflects an evolving landscape driven by advancements in technology and changing consumer preferences, revealing a broad spectrum of opportunities for growth.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharmaceutical Gelatin Market Source Insights
The Pharmaceutical Gelatin Market segment by Source plays a pivotal role in the overall landscape of the industry, projected to be valued at 3.35 billion USD by 2024. This segment comprises key categories, including Porcine, Bovine, and Fish, each with distinct advantages and applications in pharmaceuticals.
Porcine gelatin is widely recognized for its gelling properties and is often utilized in capsules and tablets, contributing significantly to the market's revenue. Bovine gelatin offers unique benefits as well, particularly in its versatile use in various pharmaceutical formulations, while Fish gelatin is gaining traction due to its plant-based appeal and lower risk of disease transmission.
The Pharmaceutical Gelatin Market data indicates a steady growth trajectory, underscored by trends like the increasing demand for gelatin-based pharmaceuticals driven by advancements in drug delivery systems. Enhanced awareness regarding health and dietary restrictions further boosts interest in Fish gelatin.
However, challenges such as regulatory requirements and source reliability remain pertinent, presenting both hurdles and opportunities for market expansion. Given the global emphasis on health and innovative drug formulations, the Source segment is anticipated to maintain its significance well into the future.
Pharmaceutical Gelatin Market Product Type Insights
The Pharmaceutical Gelatin Market encompasses two primary product types, namely Type A and Type B, which play a critical role in various pharmaceutical applications. The overall market is projected to be valued at 3.35 USD Billion in 2024, reflecting a steady demand for pharmaceutical gelatin.
Type A gelatin, derived from porcine skin, is predominantly used in applications such as capsules and tablets due to its desirable gelling properties. Meanwhile, Type B gelatin, sourced from bovine bones and skin, is significant for its application in specialty products and holds a majority market share.
This segmentation is essential as it caters to distinct industry requirements, thus driving market growth. With increasing health awareness and the rising development of biologics, the demand for both Type A and Type B gelatins is likely to continue expanding, providing ample opportunities in drug formulation.
However, the market also faces challenges, such as strict regulatory standards concerning sourcing and quality, which necessitate continuous innovation and adaptability in production processes. Overall, the Pharmaceutical Gelatin Market revenue is expected to reflect the evolving dynamics of these product types and their respective roles in the industry.
Pharmaceutical Gelatin Market End Use Insights
The Pharmaceutical Gelatin Market for End Use is projected to witness substantial growth, with the market expected to reach a valuation of 3.35 USD Billion by 2024. This segment plays a crucial role in the overall market dynamics, with various industry applications contributing to its expansion.
The pharmaceutical segment is particularly significant, as it utilizes gelatin for drug encapsulation and formulation, ensuring bioavailability and enhanced patient compliance. Concurrently, the nutraceutical sector leverages pharmaceutical gelatin for the production of dietary supplements, capitalizing on the growing trend towards health and wellness among consumers.
The cosmetics industry also increasingly adopts pharmaceutical gelatin in the formulation of skincare products, recognized for its skin-rejuvenating properties. As the Pharmaceutical Gelatin Market data reveals a projected revenue increase to 5.4 USD Billion by 2035, the market growth is supported by rising demand for animal-derived products and advancements in production technologies.
However, challenges such as sourcing sustainable raw materials remain pertinent. Overall, the Pharmaceutical Gelatin Market segmentation highlights diverse opportunities, driven primarily by innovation in pharmaceutical formulations and an expanding consumer base seeking holistic health solutions.
Pharmaceutical Gelatin Market Regional Insights
The Pharmaceutical Gelatin Market showcases diverse regional dynamics, with North America leading as a significant player valued at 1.45 USD Billion in 2024 and projected to rise to 2.3 USD Billion by 2035. This region's dominance is attributed to its strong pharmaceutical industry and high demand for gelatin in drug formulation and delivery systems.
Europe follows closely, valued at 1.0 USD Billion in 2024, expected to grow to 1.6 USD Billion by 2035, driven by an increasing emphasis on advanced drug delivery mechanisms and R&D investments.
Asia Pacific, with a valuation of 0.7 USD Billion in 2024, is anticipated to reach 1.25 USD Billion by 2035, showing robust growth owing to the expanding pharmaceutical manufacturing base and rising geriatric population. South America and the Middle East and Africa segments are smaller, valued at 0.3 USD Billion and 0.3 USD Billion in 2024, respectively, with growth projections of 0.5 USD Billion and 0.55 USD Billion by 2035, which reflects their emerging markets and gradually increasing adoption of pharmaceutical gelatin in local industries.
The Pharmaceutical Gelatin Market segmentation highlights North America's majority holding, significant European presence, and emerging potential in Asia Pacific, while the smaller regions still present growth opportunities in the global landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharmaceutical Gelatin Market Key Players and Competitive Insights
The Pharmaceutical Gelatin Market is characterized by a dynamic and competitive landscape, driven by the increasing demand for gelatin in the pharmaceutical industry. Gelatin acts as a crucial ingredient in the formulation of various drug delivery systems, including capsules, tablets, and other pharmaceutical applications. The market is witnessing advancements in manufacturing technologies, along with a growing focus on sustainable sourcing and production methods.
As the pharmaceutical sector expands globally, the competitive dynamics among key players in the gelatin space evolve, with firms striving to innovate and differentiate their products to meet the specific needs of pharmaceutical applications. The competition is also influenced by trends such as the development of vegan and vegetarian alternatives, given the rising consumer preferences for plant-based products.
Ewald Gelatine stands out in the Pharmaceutical Gelatin Market due to its strong reputation for high-quality gelatin products, which are used in various pharmaceutical applications. The company's commitment to innovation is evident in its investment in research and development, enabling it to stay at the forefront of industry trends and customer needs.
Ewald Gelatine has established a broad global presence, allowing it to serve a diverse customer base across different regions. The company's strengths lie in its robust supply chain management, ensuring consistent product availability and compliance with international quality standards. This dedication to excellence enhances its competitive positioning and fosters strong relationships with clients in the pharmaceutical industry.
PB Gelatins plays a significant role in the Pharmaceutical Gelatin Market with a diverse portfolio of key products, including various types of gelatin suitable for encapsulation and formulation needs. The company has carved out a solid market presence, bolstered by its commitment to sustainability and innovation within its production processes. A notable strength of PB Gelatins is its focus on maintaining high-quality production standards, which aligns with the stringent regulatory requirements of the pharmaceutical industry.
As part of its growth strategy, PB Gelatins has pursued strategic mergers and acquisitions, enhanced its capabilities and expanded its market reach on a global scale. This positions the company advantageously in the competitive landscape, allowing it to meet evolving market demands while reinforcing its stature as a leader in the pharmaceutical gelatin sector.
Key Companies in the Pharmaceutical Gelatin Market Include
Pharmaceutical Gelatin Market Industry Developments
The Pharmaceutical Gelatin Market has witnessed significant developments in recent months, particularly in regard to growth strategies and mergers. Ewald Gelatine and PB Gelatins have been expanding their product lines to bolster their market presence. In September 2023, Gelnex announced a strategic partnership aimed at enhancing its technological capabilities to cater to the increasing demand for gelatin-based products in pharmaceuticals. Rousselot has been actively innovating its offerings focused on sustainability, directly impacting market dynamics.
Additionally, in August 2023, Italgelatin entered a collaboration with Stero Biotechs for the development of gelatin products tailored for biopharmaceutical applications. The market is reportedly benefiting from a surge in demand for pharmaceutical capsules and advanced drug delivery systems, driven by personalized medicine trends.
In terms of market valuation, reports indicate that the sector is projected to grow significantly, with Kappa Bioscience playing a key role through its innovative solutions. The last two to three years have seen a persistent upward trajectory in the market's valuation, with advancements in gelatin manufacturing processes being a major contributing factor.
Pharmaceutical Gelatin Market Segmentation Insights
| Report Attribute/Metric | Details |
| Market Size 2023 | 3.21(USD Billion) |
| Market Size 2024 | 3.35(USD Billion) |
| Market Size 2035 | 5.4(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 4.44% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Ewald Gelatine, PB Gelatins, Eurocel, Kappa Bioscience, Nexira, Weishardt, Gelita, Seagarden, Rousselot, Nitta Gelatin, Hayashibara |
| Segments Covered | Application, Source, Product Type, End Use, Regional |
| Key Market Opportunities | Increasing demand for capsules, Growth in biopharmaceuticals, Rising prevalence of gelatin-based products, Expanding dietary supplement market, Innovations in gelatin extraction methods |
| Key Market Dynamics | Rising demand for capsules, Increasing applications in pharmaceuticals, Growth in dietary supplements, Stringent quality regulations, Shift towards plant-based alternatives. |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Pharmaceutical Gelatin Market Highlights:
Frequently Asked Questions (FAQ) :
By 2035, the Pharmaceutical Gelatin Market sizewill be valued 5.4 USD Billion.
The CAGR for the Pharmaceutical Gelatin Market from 2025 to 2035 is expected to be 4.44%.
North America is projected to hold the largest market share, valued at 2.3 USD Billion by 2035.
In 2024, the market for capsules is valued at 1.1 USD Billion and for tablets at 1.2 USD Billion.
Major players in the market include Ewald Gelatine, PB Gelatins, Eurocel, and Gelita among others.
The market value for vaccines in the Pharmaceutical Gelatin Market is projected to reach 0.5 USD Billion by 2035.
The market for pharmaceutical gelatin in Europe is expected to grow to 1.6 USD Billion by 2035.
By 2035, the forecasted market value for the Pharmaceutical Gelatin Market in South America is 0.5 USD Billion.
Increasing demand for gelatin-based pharmaceuticals and advancements in drug delivery systems are key growth drivers.
The market size for suppositories is estimated to be 1.1 USD Billion by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
